Keywords: genzyme, revenues, up, 2nd-qtr, nasdaq-listed, general, subsidiary
Genzyme revenues up 12% in 2nd-qtr
Article | 22 July 2002
Nasdaq-listed Genzyme General, a subsidiary of Genzyme Corp, hasposted revenues of $267.2 million for second-quarter 2002, an increase of 12% on the like, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
